These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11723196)

  • 1. Multiple sclerosis in sibling pairs: an analysis of 250 families.
    Chataway J; Mander A; Robertson N; Sawcer S; Deans J; Fraser M; Broadley S; Clayton D; Compston A
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):757-61. PubMed ID: 11723196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
    Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
    Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients.
    Rzepiński Ł; Zawadka-Kunikowska M; Maciejek Z; Newton JL; Zalewski P
    Medicina (Kaunas); 2019 May; 55(6):. PubMed ID: 31159275
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial effects on the clinical course of multiple sclerosis.
    Hensiek AE; Seaman SR; Barcellos LF; Oturai A; Eraksoi M; Cocco E; Vecsei L; Stewart G; Dubois B; Bellman-Strobl J; Leone M; Andersen O; Bencsik K; Booth D; Celius EG; Harbo HF; Hauser SL; Heard R; Hillert J; Myhr KM; Marrosu MG; Oksenberg JR; Rajda C; Sawcer SJ; Sørensen PS; Zipp F; Compston DA
    Neurology; 2007 Jan; 68(5):376-83. PubMed ID: 17261686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.
    Gray OM; Abdeen H; McDonnell GV; Patterson CC; Graham CA; Hawkins SA
    Mult Scler; 2009 Mar; 15(3):299-303. PubMed ID: 19244395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability progression in multiple sclerosis: a Tunisian prospective cohort study.
    Hentati E; Ben Sassi S; Nabli F; Mabrouk T; Zouari M; Hentati F
    Neurol Sci; 2018 May; 39(5):879-884. PubMed ID: 29476286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosis.
    Sorosina M; Esposito F; Guaschino C; Clarelli F; Barizzone N; Osiceanu AM; Brambilla P; Mascia E; Cavalla P; Gallo P; ; ; Martinelli V; Leone M; Comi G; D'Alfonso S; Martinelli Boneschi F
    Mult Scler; 2015 Oct; 21(11):1463-7. PubMed ID: 25533292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression in familial and nonfamilial MS.
    Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
    Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.
    Siger-Zajdel M; Selmaj K
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):752-6. PubMed ID: 11723195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.
    Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA
    Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
    Camiña-Tato M; Fernández M; Morcillo-Suárez C; Navarro A; Julià E; Edo MC; Montalban X; Comabella M
    J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
    Cocco E; Sardu C; Murru R; Frau J; Lorefice L; Mamusa E; Contu P; Marrosu MG
    Mult Scler; 2009 Sep; 15(9):1030-6. PubMed ID: 19625333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of patient-derived disability and clinical data in multiple sclerosis.
    Ingram G; Colley E; Ben-Shlomo Y; Cossburn M; Hirst CL; Pickersgill TP; Robertson NP
    Mult Scler; 2010 Apr; 16(4):472-9. PubMed ID: 20150395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
    Kremenchutzky M; Cottrell D; Rice G; Hader W; Baskerville J; Koopman W; Ebers GC
    Brain; 1999 Oct; 122 ( Pt 10)():1941-50. PubMed ID: 10506095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting risk of secondary progression in multiple sclerosis: A nomogram.
    Manouchehrinia A; Zhu F; Piani-Meier D; Lange M; Silva DG; Carruthers R; Glaser A; Kingwell E; Tremlett H; Hillert J
    Mult Scler; 2019 Jul; 25(8):1102-1112. PubMed ID: 29911467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
    Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
    Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.